$OSIS earnings report

Record Q1 Revenues of $403 Million; Record Q1 Earnings per Diluted Share; Book-to-Bill Ratio of 1.4 Drives Record Backlog of $2.1 Billion; Company Reaffirms Fiscal 2027 Revenue Guidance and Raises Fiscal 2027 Non-GAAP EPS Guidance. AlphAI read Osi Systems's fiscal 2027 first quarter filing as solid. 2 quarters are on record below.

fiscal 2027 first quarter

AlphAI · Earnings readOSIS · fiscal 2027 first quarter · ended September 30, 2026

Record Q1 Revenues of $403 Million; Record Q1 Earnings per Diluted Share; Book-to-Bill Ratio of 1.4 Drives Record Backlog of $2.1 Billion; Company Reaffirms Fiscal 2027 Revenue Guidance and Raises Fiscal 2027 Non-GAAP EPS Guidance

✓Solid quarter

Revenue, GAAP diluted EPS, non-GAAP diluted EPS, bookings, backlog and operating cash flow increased year over year, while consolidated GAAP and non-GAAP operating margins declined and Healthcare reported an operating loss.

Revenue
$403M
5% y/y
Security
$264M
Operating margin · GAAP
8.3%
EPS · non-GAAP
$1.66
17% y/y
Fiscal Year 2027 outlook
$1.875 billion - $1.930 billion

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Total net revenuesGAAP$403.5M–5%
Product revenuesGAAP$289.8M––
Service revenuesGAAP$113.6M––
Total cost of goods soldGAAP$279.7M––
Product cost of goods soldGAAP$213.8M––
Service cost of goods soldGAAP$65.88M––
Gross profitGAAP$123.8M––
Selling, general and administrative expenseGAAP$68.71M––
Research and development expenseGAAP$19.43M––
Restructuring and other chargesGAAP$2.10M––
Total operating expensesGAAP$90.23M––
Income from operationsGAAP$33.57M––
Operating marginGAAP8.3%––
Non-GAAP operating incomenon-GAAP$38.28M––
Non-GAAP operating marginnon-GAAP9.5%––
Interest and other expense, netGAAP−$3.32M––
Income before income taxesGAAP$30.25M––
Provision for income taxesGAAP−$5.68M––
Net incomeGAAP$24.57M––
Non-GAAP net incomenon-GAAP$26.95M––
Diluted earnings per shareGAAP$1.51–28%
Diluted earnings per sharenon-GAAP$1.66–17%
Weighted average shares outstanding - dilutedGAAP16.25M––
Book-to-bill ratioother1.4––
Bookingsother$583M––
Backlogother$2.1B––
Cash flow provided by operating activitiesGAAP$37.09M–>100%
Capital expendituresother$7.66M––
Cash and cash equivalentsGAAP$236.3M––
Short-term investmentsGAAP$65.70M––
Long-term debtGAAP$998.3M––
Current portion of long-term debtGAAP$1.27M––

Segments

SegmentRevenueq/qy/y
SecurityStrong bookings led to record divisional backlog and reflected robust customer demand for security inspection and surveillance products, integrated solutions, and services.$264.1M––
Optoelectronics & ManufacturingThe division benefited from vertically integrated capabilities, broad customer relationships, and a diversified manufacturing footprint.$119.7M–9% year-over-year including intersegment sales; 16% year-over-year from sales to external customers
HealthcareThe Company described Healthcare performance as soft in the quarter and anticipates a return to growth this fiscal year.$35.13M––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Fiscal Year 2027 outlook

  • Revenue$1.875 billion - $1.930 billion
  • NoteRevenue year-over-year growth rate: 5.0% - 8.1%
  • NoteNon-GAAP earnings per share: $11.28 - $11.64
  • NoteNon-GAAP earnings per share year-over-year growth rate: 9.0% - 12.5%

Capital returns

  • The board of directors authorized an additional 1 million shares to the existing share repurchase program in August 2026.
  • The Company repurchased 305,559 shares during the first quarter of fiscal 2027.
  • Total capital returned to shareholders through repurchases was approximately $62 million.
  • There were 773,172 shares remaining under the repurchase authorization as of September 30, 2026.

What drove it

  • Record first-quarter revenue and diluted EPS were led by the Security and Optoelectronics and Manufacturing divisions.
  • Bookings of $583 million produced a book-to-bill ratio of 1.4 and backlog of $2.1 billion.
  • Security bookings reflected demand for security inspection and surveillance products, integrated solutions, and services.
  • Optoelectronics and Manufacturing achieved adjusted operating margin expansion.
  • Operating cash flow more than doubled over the prior-year first quarter to $37 million.

Concerns

  • Security operating margin was impacted by a less favorable mix of revenues.
  • Healthcare reported GAAP operating income of $(2,388) (in thousands) and non-GAAP operating income of $(617) (in thousands).
  • Consolidated GAAP operating margin declined to 8.3% from 8.6%, while non-GAAP operating margin declined to 9.5% from 10.3%.
  • The Company cited continued geopolitical headwinds affecting the Security division.

What to watch

  • Whether Security revenue mix stabilizes and service revenues increase over the remainder of fiscal 2027.
  • Whether Healthcare returns to growth during fiscal 2027.
  • Conversion of the record $2.1 billion backlog and expanding opportunity pipeline into revenue.
  • Execution against reaffirmed revenue guidance of $1.875 billion - $1.930 billion and increased non-GAAP EPS guidance of $11.28 - $11.64.

Balance sheet and cash flow

  • Cash flow provided by operating activities was $37,088 (in thousands), compared with $17,137 (in thousands) for the three months ended September 30, 2025.
  • Capital expenditures were $7,655 (in thousands), compared with $7,028 (in thousands) for the three months ended September 30, 2025.
  • Cash and cash equivalents were $236,298 (in thousands) and short-term investments were $65,702 (in thousands) as of September 30, 2026.
  • Long-term debt was $998,294 (in thousands) and the current portion of long-term debt was $1,275 (in thousands) as of September 30, 2026.

Analysis

OSI Systems began fiscal 2027 with total net revenues of $403,472 (in thousands), compared with $384,623 (in thousands), a reported increase of 5%. GAAP diluted EPS rose 28% to $1.51 and non-GAAP diluted EPS rose 17% to $1.66. Net income was $24,572 (in thousands), compared with $20,556 (in thousands), while non-GAAP net income was $26,953 (in thousands), compared with $24,836 (in thousands).

Demand indicators were strong. Bookings of $583 million produced a 1.4 book-to-bill ratio, compared with 1.1, and backlog reached $2.1 billion from $1.9 billion as of June 30, 2026. Management attributed Security bookings to demand for inspection and surveillance products, integrated solutions, and services. Optoelectronics and Manufacturing revenue reached $119,725 (in thousands), with management reporting 9% year-over-year growth including intersegment sales and 16% growth in external sales.

Profitability was mixed. Consolidated GAAP operating income increased to $33,570 (in thousands) from $33,073 (in thousands), but GAAP operating margin declined to 8.3% from 8.6%. Non-GAAP operating income declined to $38,280 (in thousands) from $39,778 (in thousands), and non-GAAP operating margin declined to 9.5% from 10.3%. Security's non-GAAP operating margin declined to 12.6% from 13.5%, which management attributed to less favorable revenue mix. Healthcare revenue was $35,128 (in thousands) and its GAAP and non-GAAP operating results were losses.

Cash generation improved materially, with cash flow provided by operating activities of $37,088 (in thousands), compared with $17,137 (in thousands). The Company repurchased 305,559 shares and reported approximately $62 million of capital returned through repurchases. Cash and cash equivalents plus short-term investments were approximately $302 million, while long-term debt was $998,294 (in thousands).

The Company reaffirmed fiscal 2027 revenue guidance of $1.875 billion - $1.930 billion and increased non-GAAP EPS guidance to $11.28 - $11.64 from $11.13 - $11.49. The updated non-GAAP EPS growth range is 9.0% - 12.5%, compared with the prior 7.5% - 11.0% range. The key operating focus is whether Security mix improves as service revenue increases, alongside a recovery in Healthcare and conversion of backlog into revenue.

Management, verbatim

We are pleased to begin fiscal 2027 with record first quarter revenues and earnings per share, led by the performance of our Security and Optoelectronics and Manufacturing divisions.

Ajay Mehra, President and Chief Executive Officer

The Security division delivered a solid quarter despite continued geopolitical headwinds.

Ajay Mehra, President and Chief Executive Officer

Operating cash flow more than doubled in the first fiscal quarter over the prior year Q1 to $37 million, and we finished the quarter with approximately $302 million of cash, cash equivalents and short-term investments.

Alan Edrick, Executive Vice President and Chief Financial Officer

Not in the filing

stated, not guessed
  • Free cash flow was not reported.
  • GAAP gross margin was not reported.
  • GAAP fiscal 2027 diluted EPS guidance was not provided.
  • Fiscal 2027 guidance for gross margin, operating expenses and tax rate was not provided.
  • Dividend information was not reported.
  • A previous-release outlook was not provided for comparison with reported first-quarter results.
  • Prior-year and prior-quarter comparisons were not printed for several individual financial-statement line items and segment revenues.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Fiscal 2026 fourth quarter and fiscal year

AlphAI · Earnings readOSIS · Fiscal 2026 fourth quarter and fiscal year · ended June 30, 2026

OSI Systems reports record fiscal 2026 revenues of $1.79 billion, record fourth-quarter non-GAAP EPS of $3.78, record fiscal-year operating cash flow of $276 million, and fiscal 2027 revenue and non-GAAP EPS guidance.

✓Solid quarter

Fiscal-year revenue, GAAP EPS, non-GAAP EPS and operating cash flow increased year over year, while fourth-quarter revenue declined 4% amid Middle East delivery disruptions. Fourth-quarter profitability and cash generation were strong, backlog reached approximately $1.9 billion, and fiscal 2027 guidance calls for revenue and non-GAAP EPS growth.

Revenue
$484M
-4% y/y
Security, fourth quarter
$340M
Operating margin · GAAP
15.3%
EPS · non-GAAP
$3.78
17% y/y
Fiscal Year 2027 outlook
$1.875 billion - $1.930 billion; YoY Growth Rate 5.0% - 8.1%

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Fourth-quarter total net revenuesGAAP$484.1M–-4%
Fiscal-year total net revenuesGAAP$1.79B–4%
Fourth-quarter product revenuesGAAP$373.2M––
Fourth-quarter service revenuesGAAP$110.8M––
Fiscal-year product revenuesGAAP$1.34B––
Fiscal-year service revenuesGAAP$441.3M––
Fourth-quarter gross profitGAAP$168.0M––
Fiscal-year gross profitGAAP$593.1M––
Fourth-quarter income from operationsGAAP$73.89M––
Fourth-quarter operating marginGAAP15.3%––
Fourth-quarter non-GAAP operating incomenon-GAAP$85.5M––
Fourth-quarter non-GAAP operating marginnon-GAAP17.7%––
Fiscal-year income from operationsGAAP$219.0M––
Fiscal-year operating marginGAAP12.3%––
Fiscal-year non-GAAP operating incomenon-GAAP$253.3M––
Fiscal-year non-GAAP operating marginnon-GAAP14.2%––
Fourth-quarter net incomeGAAP$55.24M––
Fiscal-year net incomeGAAP$154.7M––
Fourth-quarter diluted earnings per shareGAAP$3.27–8%
Fourth-quarter diluted earnings per sharenon-GAAP$3.78–17%
Fiscal-year diluted earnings per shareGAAP$8.95–3%
Fiscal-year diluted earnings per sharenon-GAAP$10.35–11%
Fourth-quarter weighted average shares outstanding – dilutedGAAP16.91M––
Fiscal-year weighted average shares outstanding – dilutedGAAP17.28M––
Fourth-quarter cash flow provided by operating activitiesGAAP$182.1M––
Fiscal-year cash flow provided by operating activitiesGAAP$275.9M––
Fourth-quarter capital expendituresGAAP$9.30M––
Fiscal-year capital expendituresGAAP$30.57M––
Backlog as of June 30, 2026otherapproximately $1.9 billion––

Segments

SegmentRevenueq/qy/y
Security, fourth quarterRevenues were impacted by disruptions from the Middle East conflicts that shifted the timing of certain planned deliveries; the company reported healthy bookings, substantial backlog and a significant opportunity pipeline.$339.7M––
Optoelectronics & Manufacturing, fourth quarterBroad-based demand across several key end markets, including aerospace, defense, healthcare, technology and industrial customers.$117.8M–up about 5% year-over-year
Healthcare, fourth quarterOperational improvements implemented throughout the year; the company is focused on expanding its installed base, clinical solutions and product development.$44.75M–up approximately 5%
Security, fiscal yearThe division ended the year with substantial backlog, a significant opportunity pipeline and recent program wins.$1.25B––
Optoelectronics & Manufacturing, fiscal yearThe company cited demand across several key end markets and its highly engineered products, precision manufacturing capabilities and global operational reach.$450.8M––
Healthcare, fiscal yearThe company cited operational improvements and initiatives to expand the installed base and advance product development.$162.7M––

Fiscal Year 2027 outlook

  • Revenue$1.875 billion - $1.930 billion; YoY Growth Rate 5.0% - 8.1%
  • NoteNon-GAAP Diluted Earnings Per Share: $11.13 - $11.49
  • NoteNon-GAAP Diluted Earnings Per Share YoY Growth Rate: 7.5% - 11.0%
  • NoteThe company provides fiscal 2027 diluted EPS guidance on a non-GAAP basis only and does not provide a forward-looking reconciliation to GAAP diluted EPS.

Capital returns

  • The company repurchased 564,880 shares during the fiscal 2026 fourth quarter for an aggregate cash amount of $123.6 million.
  • The company continued to return capital to shareholders through stock repurchases during fiscal 2026.

What drove it

  • Fiscal-year revenues increased 4% to $1,785,984 thousand.
  • Fourth-quarter GAAP diluted EPS increased 8% to $3.27 and non-GAAP diluted EPS increased 17% to $3.78.
  • The Security division reported strong profitability, outstanding cash generation and healthy bookings.
  • Optoelectronics & Manufacturing fourth-quarter revenue rose about 5% year over year on broad-based demand.
  • Healthcare fourth-quarter revenue increased approximately 5%, while non-GAAP operating margin was 10.0% compared with 0.9% in the prior-year quarter.
  • Backlog was approximately $1.9 billion as of June 30, 2026, compared with $1.8 billion a year ago.

Concerns

  • Fourth-quarter total net revenues declined 4% to $484,058 thousand.
  • The company cited Middle East conflicts as causing disruptions and shifting the timing of certain planned Security deliveries.
  • Fiscal-year Security GAAP operating margin was 16.1%, compared with 17.1% in fiscal 2025.
  • Fiscal-year Healthcare revenue was $162,729 thousand versus $168,362 thousand in fiscal 2025, and GAAP operating income was negative $33 thousand versus $2,462 thousand.
  • Fiscal-year impairment, restructuring and other charges, net were $16,591 thousand, compared with $5,335 thousand in fiscal 2025.
  • Long-term debt was $998,518 thousand as of June 30, 2026, compared with $463,504 thousand a year earlier.

What to watch

  • The timing of Security deliveries affected by Middle East conflicts and conversion of delayed backlog into revenue.
  • Security bookings, backlog and progress on recent program wins.
  • Sustainability of Healthcare operational improvements, including its 10.0% fourth-quarter non-GAAP operating margin.
  • Execution against fiscal 2027 revenue guidance of $1.875 billion - $1.930 billion and non-GAAP diluted EPS guidance of $11.13 - $11.49.
  • Cash generation, debt management after the fiscal 2026 refinancing and expanded long-term debt, and ongoing share repurchases.

Balance sheet and cash flow

  • Cash and cash equivalents were $359,832 thousand as of June 30, 2026, compared with $106,405 thousand as of June 30, 2025.
  • Accounts receivable, net were $764,626 thousand as of June 30, 2026, compared with $837,743 thousand as of June 30, 2025.
  • Inventories were $415,562 thousand as of June 30, 2026, compared with $407,174 thousand as of June 30, 2025.
  • Bank lines of credit were $0 as of June 30, 2026, compared with $178,000 thousand as of June 30, 2025.
  • Current portion of long-term debt was $2,531 thousand and long-term debt was $998,518 thousand as of June 30, 2026, compared with $8,130 thousand and $463,504 thousand, respectively, as of June 30, 2025.
  • During fiscal 2026, the company refinanced and expanded its long-term debt, extended maturities, and enhanced financial flexibility to fund growth initiatives.
  • Fourth-quarter cash flow provided by operating activities was $182,110 thousand, compared with $561 thousand in the prior-year quarter.
  • Fiscal-year cash flow provided by operating activities was $275,904 thousand, compared with $97,592 thousand in fiscal 2025.

Analysis

OSI Systems closed fiscal 2026 with revenue of $1,785,984 thousand, up 4% from fiscal 2025, while GAAP diluted EPS increased 3% to $8.95 and non-GAAP diluted EPS increased 11% to $10.35. Fourth-quarter revenue declined 4% to $484,058 thousand, but GAAP diluted EPS rose 8% to $3.27 and non-GAAP diluted EPS rose 17% to $3.78. The company attributed the quarterly revenue pressure to Middle East conflicts that shifted planned Security deliveries, while stating that the delayed orders remain in backlog with updated delivery schedules.

Segment performance was uneven. Security fourth-quarter revenue was $339,733 thousand and the company cited strong profitability, cash generation and healthy bookings, but disruptions affected delivery timing. Optoelectronics & Manufacturing generated $117,806 thousand of fourth-quarter revenue, up about 5% year over year on broad-based demand across key end markets. Healthcare generated $44,751 thousand, up approximately 5%, and posted 10.0% non-GAAP operating margin versus 0.9% in the prior-year quarter. That quarterly Healthcare margin improvement contrasts with fiscal-year Healthcare GAAP operating income of negative $33 thousand.

Profitability improved in the fourth quarter despite the revenue decline. GAAP operating margin was 15.3%, compared with 14.5% a year earlier, and non-GAAP operating margin was 17.7%, compared with 15.7%. For the fiscal year, GAAP operating margin declined to 12.3% from 12.7%, while non-GAAP operating margin increased to 14.2% from 14.1%. Fiscal-year impairment, restructuring and other charges increased to $16,591 thousand from $5,335 thousand, which was a meaningful item in the GAAP-to-non-GAAP reconciliation.

Cash flow was the central financial strength of the release. Fourth-quarter operating cash flow was a record $182,110 thousand versus $561 thousand a year earlier, and fiscal-year operating cash flow reached a record $275,904 thousand versus $97,592 thousand. Cash and cash equivalents increased to $359,832 thousand from $106,405 thousand. The company repurchased 564,880 shares for $123.6 million during the fourth quarter, refinanced and expanded long-term debt, and reduced bank lines of credit to zero, while long-term debt rose to $998,518 thousand from $463,504 thousand.

Fiscal 2027 guidance calls for revenue of $1.875 billion to $1.930 billion and non-GAAP diluted EPS of $11.13 to $11.49. The guide is underpinned by approximately $1.9 billion of backlog, compared with $1.8 billion a year ago, alongside a significant opportunity pipeline and recent program wins. The key operating issue is whether delayed Security deliveries convert on the updated schedule while the company sustains Optoelectronics & Manufacturing demand, Healthcare margin progress and elevated cash generation.

Management, verbatim

Fiscal 2026 was a strong year for the Company, capped by record fourth quarter non-GAAP earnings per share and record operating cash flow, despite the impact of revenue headwinds from the Middle East conflicts which shifted the timing of certain planned deliveries.

Ajay Mehra, President and Chief Executive Officer

While revenues were impacted by disruptions from the Middle East conflicts, underlying demand for our products and services remain encouraging. These delays do not reflect order cancellations and remain in our backlog with updated delivery schedules.

Ajay Mehra, President and Chief Executive Officer

The Healthcare division delivered an improved fourth quarter, with revenues up approximately 5% and an adjusted operating margin of 10% compared with 1% in the prior-year quarter, demonstrating the impact of operational improvements implemented throughout the year.

Ajay Mehra, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Previous-quarter outlook was not provided, so no comparison of actual results with prior guidance is available.
  • Free cash flow was not reported.
  • GAAP gross margin and non-GAAP gross margin were not reported.
  • Fiscal 2027 guidance for gross margin, operating expenses, tax rate, operating cash flow, capital expenditures, backlog and GAAP diluted EPS was not reported.
  • Dividend information was not reported.
  • Quarter-over-quarter comparisons were not reported.
  • Forward-looking GAAP diluted EPS guidance and a reconciliation of fiscal 2027 non-GAAP diluted EPS guidance to GAAP diluted EPS were not provided.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about OSIS earnings dates

When is Osi Systems's next earnings date?
AlphAI has no date for OSIS yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.